Intramuscular administration of a synthetic CpG-oligodeoxynucleotide modulates functional responses of neutrophils of neonatal foals

PLoS ONE

Volumn 9, Issue 10, 2014, Pages

  Cohen, Noah D ^a   Bourquin, Jessica R ^a   Bordin, Angela I ^a   Kuskie, Kyle R ^a   Brake, Courtney N ^a   Weaver, Kaytee B ^a   Liu, Mei ^a   Felippe, M Julia B ^b   Kogut, Michael H ^c  

^a TEXAS A AND M UNIVERSITY   (United States)

^b Department of Clinical Sciences College of Veterinary Medicine Cornell University ^*  (United States)

^c SOUTHERN PLAINS AGRICULTURAL RESEARCH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA GLUCURONIDASE; CPG OLIGODEOXYNUCLEOTIDE; GAMMA INTERFERON; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; REACTIVE OXYGEN METABOLITE; CPG-OLIGONUCLEOTIDE; CYTOKINE; OLIGODEOXYRIBONUCLEOTIDE;

ADAPTIVE IMMUNITY; AGE DISTRIBUTION; ANIMAL CELL; ARTICLE; CELL ISOLATION; DEGRANULATION; DRUG EFFICACY; DRUG RESPONSE; ENZYME ACTIVITY; FOAL; GENE EXPRESSION; IMMUNE RESPONSE; IN VIVO STUDY; INNATE IMMUNITY; NEUTROPHIL; NEUTROPHIL COUNT; NEWBORN; NONHUMAN; RHODOCOCCUS EQUI; ANIMAL; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HORSE; IMMUNOLOGY; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; METABOLISM;

RHODOCOCCUS EQUI;

ANIMALS; ANIMALS, NEWBORN; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION; HORSES; INJECTIONS, INTRAMUSCULAR; MALE; NEUTROPHILS; OLIGODEOXYRIBONUCLEOTIDES; REACTIVE OXYGEN SPECIES;

EID: 84908022128     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0109865     Document Type: Article

References (51)

1. Giguère S, Cohen ND, Chaffin MK, Slovis NM, Hondalus MK, et al. (2011) Diagnosis, treatment, control, and prevention of infections caused by Rhodococcus equi in foals. J Vet Intern Med 25:1209-1220.
2. Magdesian KG, Hirsh DC, Jang SS, Hansen LM, Madigan JE. (2002) Characterization of Clostridium difficile isolates from foals with diarrhea: 28 cases (1993-1997). J Am Vet Med Assoc 220:67-73.
3. East LM, Dargatz DA, Traub-Dargatz JL, Savage CJ. (2000) Foalingmanagement practices associated with the occurrence of enterocolitis attributed to Clostridium perfringens infection in the equine neonate. Prev Vet Med 46:61-74.
4. Frederick J, Giguère S, Sanchez LC. (2009) Infectious agents detected in the feces of diarrheic foals: a retrospective study of 233 cases (2003-2008). J Vet Intern Med 23:1254-1260.
5. Burton AJ, Nydam DV, Dearen TK, Mitchell K, Bowman DD, et al. (2010) The prevalence of Cryptosporidium, and identification of the Cryptosporidium horse genotype in foals in New York State. Vet Parasitol 174:139-144.
6. Marsh PS, Palmer JE. (2001) Bacterial isolates from blood and their susceptibility patterns in critically ill foals: 543 cases (1991-1998). J Am Vet Med Assoc 218:1608-1610.
7. Corley KT, Pearce G, Magdesian KG, Wilson WD. (2007) Bacteraemia in neonatal foals: clinicopathological differences between Gram-positive and Gram-negative infections, and single organism and mixed infections. Equine Vet J 39:84-9.
8. Cohen ND. (1994) Causes of and farm management factors associated with morbidity and mortality in foals. J Am Vet Med Assoc 204:1644-1651.
9. Anonymous. (1999) Part I: Baseline Reference of 1998 Equine Health Management. USDA-APHIS, Veterinary Services Report, pp. 34-46. Available: http://www.aphis.usda.gov/animal-health/nahms/equine/downloads/equine98/Equine98-dr-PartI.pdf. Accessed 2013 April 5.
10. Cuenca AG, Wynn JL, Moldawer LL, Levy O. (2013) Role of innate immunity in neonatal infection. Am J Perinatol 30:105-112.
11. Levy O. (2007) Innate immunity of the newborn: basic mechanisms and clinical correlates. Nat Rev Immunol 7:379-390.
12. Jaillon S, Galdiero MR, Del Prete D, Cassatella MA, Garlanda C, et al. (2013) Neutrophils in innate and adaptive immunity. Semin Immunopathol 35:377-394.
13. Martens RJ, Cohen ND, Jones SL, Moore TA, Edwards JF. (2005) Protective role of neutrophils in mice experimentally infected with Rhodococcus equi. Infect Immun 73:7040-7042.
14. Chaffin MK, Cohen ND, Martens RJ, Edwards RF, Nevill M, et al. (2004) Hematologic and immunophenotypic factors associated with development of Rhodococcus equi pneumonia of foals at equine breeding farms with endemic infection. Vet Immunol Immunopathol 100:33-48.
15. Koenig JM, Yoder MC. (2004) Neonatal neutrophils: the good, the bad, and the ugly. Clin Perinatol 31:39-51.
16. Wichtel MG, Anderson KL, Johnson TV, Nathan U, Smith L. (1991) Influence of age on neutrophil function in foals. Equine Vet J 23:466-469.
17. Grondahl G, Johannisson A, Demmers S, Jensen Waern M. (1999) Influence of age and plasma treatment on neutrophil phagocytosis and CD18 expression in foals. Vet Microbiol 65:241-254.
18. Flaminio MJBF, Rush BR, Davis ER, Hennessy K, Shuman W, et al. (2000) Characterization of peripheral blood and pulmonary leukocyte function in healthy foals. Vet Immunol Immunopathol 73:267-285.
19. Dawson DR, Nydam DV, Price CT, Graham JE, Cynamon MH, et al. (2011) Effects of opsonization of Rhodococcus equi on bacterial viability and phagocyte activation. Am J Vet Res 72:1465-1475.
20. Martens JG, Martens RJ, Renshaw HW. (1988) Rhodococcus (Corynebacterium) equi: bactericidal capacity of neutrophils from neonatal and adult horses. Am J Vet Res 49:295-299.
21. McTaggart C, Yovich JV, Penhale J, Raidal SL. (2001) A comparison of foal and adult horse neutrophil function using flow cytometric techniques. Res Vet Sci 71:73-79.
22. Nerren JR, Martens RJ, Payne S, Murrell J, Butler JL, et al. (2009) Age-related changes in cytokine expression by neutrophils of foals stimulated with virulent Rhodococcus equi in vitro. Vet Immunol Immunopathol 127:212-219.
23. Bordin AI, Liu M, Nerren JR, Buntain SL, Brake CN, et al. (2012) Neutrophil function of neonatal foals is enhanced in vitro by CpG oligodeoxynucleotide stimulation. Vet Immunol Immunopathol 145:290-7.
24. Liu M, Liu T, Bordin A, Nerren J, Cohen N. (2009) Activation of foal neutrophils at different ages by CpG oligodeoxynucleotides and Rhodococcus equi. Cytokine 48:280-289.
25. Alves MP, Guzylack-Piriou L, Juillard V, Audonnet JC, Doel T, et al. (2009) Innate immune defenses induced by CpG do not promote vaccine-induced protection against foot-and-mouth disease virus in pigs. Clin Vaccine Immunol 16:1151-1157.
26. Ioannou XP, Griebel P, Hecker R, Babiuk LA, van Drunen Little-van den Hurk S. (2002) The immunogenicity and protective efficacy of bovine herpesvirus 1 glycoprotein D plus Emulsigen are increased by formulation with CpG oligodeoxynucleotides. J Virol 76:9002-9010.
27. Oumouna M, Mapletoft JW, Karvonen BC, Babiuk LA, van Drunen Littel-van den Hurk S. (2005) Formulation with CpG oligodeoxynucleotides prevents induction of pulmonary immunopathology following priming with formalininactivated or commercial killed bovine respiratory syncytial virus vaccine. J Virol 79:2024-2032.
28. Nichani AK, Mena A, Popowych Y, Dent D, Townsend HGG, et al. (2004) In vivo immunostimulatory effects of CpG oligodeoxynucleotide in cattle and sheep. Vet Immunol Immunopathol 98:17-29.
29. Nichani AK, Kaushik RS, Mena A, Popowych Y, Dent D, et al. (2004) CpG oligodeoxynucleotide induction of antiviral effector molecules in sheep, Cell Immunol 227:24-37.
30. Vordermeier HM, Pontarollo R, Karvonen B, Cockle P, Hecker R, et al. (2005) Synthetic peptide vaccination in cattle: induction of strong cellular immune responses against peptides derived from the Mycobacterium bovis antigen Rv3019c. Vaccine 2005;23:4375-4384.
31. Wedlock DN, Skinner MA, de Lisle GW, Vordermeier HM, Hewinson RG, et al. (2005) Vaccination of cattle with Mycobacterium bovis culture filtrate proteins and CpG oligodeoxynucleotides induces protection against bovine tuberculosis. Vet Immunol Immunopathol 106:53-63.
32. Wedlock DN, Denis M, Skinner MA, Koach J, de Lisle GW, et al. (2005) Vaccination of cattle with a CpG oligodeoxynucleotide-formulated mycobacterial protein vaccine and Mycobacterium bovis BCG induces levels of protection against bovine tuberculosis superior to those induced by vaccination with BCG alone. Infect Immun 73:3540-3546.
33. Lopez AM, Hecker R, Mutwiri G, van Drunen Littel-van den Hurk S, Babiuk LA, et al. (2006) Formulation with CpG ODN enhances antibody responses to an equine influenza virus vaccine. Vet Immunol Immunopathol 114:103-110.
34. Mutwiri GK, Nichani AK, Babiuk S, Babiuk LA. (2004) Strategies for enhancing the immunostimulatory effects of CpG oligodeoxynucleotides. J Controlled Release 97:17.
35. Shafique M, Wilschut J, de Haan A. (2012) Induction of mucosal and systemic immunity against respiratory syncytial virus by inactivated virus supplemented with TLR9 and NOD2 ligands. Vaccine 30:597-606.
36. Boyd NK, Cohen ND, Lim WS, Martens RJ, Chaffin MK, et al. (2004) Temporal changes in cytokine expression of foals during the first month of life. Vet Immunol Immunopathol 2004;92:75-85.
37. Breathnach CC, Sturgill-Wright T, Stiltner JL, Adams AA, Lunn DP, et al. (2006) Foals are interferon gamma-deficient at birth. Vet Immunol Immunopathol 2006;112:199-209.
38. Liu M, Bordin A, Liu T, Russell K, Cohen N. (2011) Gene expression of innate Th1-, Th2-, and Th17-type cytokines during early life of neonatal foals in response to Rhodococcus equi. Cytokine 2011;56:356-364.
39. Liu T, Nerren J, Liu M, Martens R, Cohen N. (2009) Basal and stimulusinduced cytokine expression is selectively impaired in peripheral blood mononuclear cells of newborn foals. Vaccine 2009;27:674-683.
40. Sumino K, Tucker J, Shahab M, Jaffee KF, Visness CM, et al. (2012) Antiviral IFN-c responses of monocytes at birth predict respiratory tract illness in the first year of life. J Allergy Clin Immunol 129:1267-1273.
41. Yamaguchi Y, Harker JA, Wang B, Openshaw PJ, Tregoning JS, et al. (2012) Preexposure to CpG protects against the delayed effects of neonatal respiratory syncytial virus infection. J Virol 86:10456-10461.
42. Fabri M, Stenger S, Shin D-M, Yuk J-M, Liu PT, et al. (2011) Vitamin D is required for IFN-c-mediated antimicrobial activity of human macrophages. Science Translational Medicine 3:1-10.
43. Brandt E, Woerly G, Ben-Younes A, Louiseau S, Capron M. (2000) IL-4 production by human polymorphonuclear neutrophils. J Leukocyte Biol 68:125-130.
44. Snoeck HW, Lardon F, Lenjou M, Nys G, Van Bockstaele DR, et al. (1993) Interferon-g and interleukin-4 reciprocally regulate the production of monocytes/macrophages and neutrophils through a direct effect on committed monopotential bone marrow progenitor cells. Eur J Immunol 23:1072-1077.
45. Bober LA, Waters TA, Pugliese-Sivo CC, Sullivan LM, Narula SK, et al. (1995) IL-4 induces neutrophilic maturation of HL-60 cells and activation of human peripheral blood neutrophils. Clin Exp Immunol 99:129-136.
46. Girard D, Paquin R, Beaulieu AD. (1997) Responsiveness of human neutrophils to interleukin-4: induction of cytoskeletal rearrangements, de novo protein synthesis and delay of apoptosis. Biochem J 325:147-153.
47. Faurschou M, Borregaard N. (2003) Neutrophil granules and secretory vesicles in inflammation. Microbes Infect 5:1317-1327.
48. Harvey JW, Asquith RL, McNulty PK, Kivipelto J, Bauer JE. (1984) Hematology of foals up to one year old. Equine Vet J 16:347-353.
49. Kirby AC, Yrlid U, Wick MJ. (2002) The innate immune response differs in primary and secondary Salmonella infection. J Immunol 169:4450-4459.
50. Yin J, Ferguson TA. (2009) Identification of an IFN-c-producing neutrophil early in the response to Listeria monocytogenes. J Immunol 182:7069-7073.
51. Deng JC, Moore TA, Newstead MW, Zeng X, Krieg AM, et al. (2004) CpG oligodeoxynucleotides stimulate protective innate immunity against pulmonary Klebsiella infection. J Immunol 173:5148-5155.